Lawrence A. Kenyon
President, Chief Executive Officer and Chief Financial Officer
Outlook Therapeutics is a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab (LYTENAVA™ or bevacizumab-vikg), for use in retinal indications, including wet AMD, DME and BRVO.
Gary Wilcox, Ph.D.
Chairman of the Board and Chief Executive Officer
Cocrystal is a biotechnology company discovering & developing novel antiviral therapeutics that target the replication machinery of influenza virus, hepatitis C virus, noroviruses & coronaviruses through utilizing its structure-based technologies.
Jeffrey F. Eisenberg
Chief Executive Officer
Xenetic is a biopharmaceutical company focused on progressing XCART™, a personalized CAR T platform technology engineered to target patient- & tumor-specific neoantigens, initially being advanced for the treatment of B-cell lymphomas.
Gilles Gagnon, M.Sc., MBA
President and Chief Executive Officer
Ceapro Inc. is a biotechnology company involved in the development & commercialization of “active ingredients” derived from oats & other renewable plant resources for healthcare and cosmetic industries utilizing its proprietary extraction technology.
Chief Executive Officer, President and Director
Guardion is a specialty health sciences company (i) that has developed medical foods & medical devices in the ocular health marketplace & (ii) that is developing nutraceuticals that it believes will provide medicinal
and health benefits to consumers.
Mark C. Jensen
Chief Executive Officer and Chairman of Board
American Resources is a supplier of high-quality raw materials to the rapidly growing global infrastructure market. The Company is focused on the extraction
and processing of metallurgical carbon, an essential ingredient used in steelmaking.
Chief Executive Officer, Co-Founder
Charge is a micromobility company dedicated to building the largest network of electric charging, storage and service stations for e-scooters and e-bikes.
© 2020 Virtual Investor Summit All rights reserved.
President, Chief Executive Officer and Director
TFF Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology, which can improve the absorption of poorly water-soluble drugs.